The firm plans to use the proceeds to support its commercialization and R&D activities as well as for working capital and general corporate purposes.
The ABBOTT PRISM System is an automated immunoassay analyzer designed to perform Chemiluminescent immunoassay (ChLIA) technology. The ABBOTT PRISM performs batch/continuous access and STAT ...
The US Food and Drug Administration (FDA) has cleared Revvity’s automated chemiluminescence-based immunoassay (ChLIA) test for free testosterone. The authorisation by the agency marks the first ...
A research team at UCLA has developed a deep learning-powered chemiluminescence vertical flow assay (CL-VFA) that brings ...
These chemiluminescent, no-wash assays are ideally ... advantageously with conventional enzyme-linked immunosorbent assay (ELISA). ELISA is the most widely used detection platform for the ...
The global immunodiagnostics market size is calculated at USD 24.20 billion in 2025 and is expected to reach around USD 70.9 ...
Fapon at Medlab Middle East 2025: Advancing Local Diagnostic Industry through One-stop IVD Solutions
At the exhibition, Fapon has presented a range of IVD solutions covering a wide spectrum of technology applications, including chemiluminescence immunoassay (CLIA), biochemistry, next-generation ...
Immunoassay technologies include analytical methods like fluorescence immunoassays, chemiluminescent immunoassays, radioimmunoassays, lateral flow assays, immunofluorescence assays, multiplex assays, ...
More information: Gyeo‐Re Han et al, Deep Learning‐Enhanced Chemiluminescence Vertical Flow Assay for High‐Sensitivity Cardiac Troponin I Testing, Small (2025). DOI: 10.1002/smll.202411585 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback